News

Arbor Biotechnologies

Arbor Biotechnologies Closes $215 Million Oversubscribed Series B Financing

NOVEMBER 9, 2021

Entrada Therapeutics

Entrada Therapeutics Announces Pricing of Upsized Initial Public Offering

OCTOBER 28, 2021

ShouTi

ShouTi Secures $100 Million Series B Financing

OCTOBER 20, 2021

Obsidian

Obsidian Therapeutics Announces Closing of $115 Million Series B Financing

SEPTEMBER 9, 2021

Artios

Artios Announces $153 Million Series C Financing

JULY 27, 2021

RayzeBio

RayzeBio Secures $108 Million Series C Financing

JUNE 15, 2021

Synthekine

Synthekine Announces $107.5 Million Oversubscribed Series B Financing

JUNE 10, 2021

Affinia Therapeutics

Affinia Therapeutics Closes $110 Million Series B Financing

MAY 3, 2021

TCG X

TCG X Raises Inaugural $824 Million Fund to Advance Disruptive Medicines

APRIL 20, 2021

Entrada Therapeutics

Entrada Therapeutics Announces Closing of $116 Million Series B Financing

MARCH 31, 2021

Aktis Oncology

Aktis Oncology Announces $72 Million Series A Financing to Advance Breakthrough Radiopharmaceuticals

MARCH 18, 2021